172 related articles for article (PubMed ID: 9885204)
1. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis.
Weiss M; Moldawer LL; Schneider EM
Blood; 1999 Jan; 93(2):425-39. PubMed ID: 9885204
[No Abstract] [Full Text] [Related]
2. Granulocyte colony-stimulating factor as the expecting sword for the treatment of severe sepsis.
Murata A
Curr Pharm Des; 2003; 9(14):1115-20. PubMed ID: 12769751
[TBL] [Abstract][Full Text] [Related]
3. Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.
Fang H; Jiang W; Cheng J; Lu Y; Liu A; Kan L; Dahmen U
J Immunol Res; 2015; 2015():187048. PubMed ID: 26798659
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic granulocyte colony-stimulating factor in the critically ill: carefully balancing the benefits and risks.
Quezado ZM; Eichacker PQ
Crit Care Med; 2002 Sep; 30(9):2162-4. PubMed ID: 12352068
[No Abstract] [Full Text] [Related]
5. Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis.
Nelson S; Bagby GJ
Clin Chest Med; 1996 Jun; 17(2):319-32. PubMed ID: 8792069
[TBL] [Abstract][Full Text] [Related]
6. Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases.
Dale DC; Liles WC; Summer WR; Nelson S
J Infect Dis; 1995 Oct; 172(4):1061-75. PubMed ID: 7561181
[No Abstract] [Full Text] [Related]
7. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis.
Banerjea MC; Speer CP
Semin Neonatol; 2002 Aug; 7(4):335-49. PubMed ID: 12401303
[TBL] [Abstract][Full Text] [Related]
8. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
[TBL] [Abstract][Full Text] [Related]
9. Myeloid colony-stimulating factors: use in the newborn.
Sreenan C; Osiovich H
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor improves host defense to resuscitated shock and polymicrobial sepsis without provoking generalized neutrophil-mediated damage.
Patton JH; Lyden SP; Ragsdale DN; Croce MA; Fabian TC; Proctor KG
J Trauma; 1998 May; 44(5):750-8; discussion 758-9. PubMed ID: 9603074
[TBL] [Abstract][Full Text] [Related]
11. Infection, sepsis and systemic inflammatory response syndrome in obstructive jaundice.
Whalan C; Drew P; Maddern G
J Gastroenterol Hepatol; 1998 Apr; 13(4):354-5. PubMed ID: 9641296
[No Abstract] [Full Text] [Related]
12. Is G-CSF safe and useful in the treatment of infectious diseases in the non-neutropenic host?
Pajkrt D; van Deventer SJ
Intensive Care Med; 1997 Jan; 23(1):1-2. PubMed ID: 9037632
[No Abstract] [Full Text] [Related]
13. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory mechanisms of sepsis.
Shubin NJ; Monaghan SF; Ayala A
Contrib Microbiol; 2011; 17():108-124. PubMed ID: 21659749
[TBL] [Abstract][Full Text] [Related]
15. A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life.
Rosenthal J; Healey T; Ellis R; Gillan E; Cairo MS
J Pediatr; 1996 Jan; 128(1):135-7. PubMed ID: 8551404
[TBL] [Abstract][Full Text] [Related]
16. A Review of GM-CSF Therapy in Sepsis.
Mathias B; Szpila BE; Moore FA; Efron PA; Moldawer LL
Medicine (Baltimore); 2015 Dec; 94(50):e2044. PubMed ID: 26683913
[TBL] [Abstract][Full Text] [Related]
17. Sepsis in the critically ill patient.
Baker CC; Huynh MD
Curr Probl Surg; 1995 Dec; 32(12):1013-83. PubMed ID: 7497736
[No Abstract] [Full Text] [Related]
18. Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats.
Lundblad R; Wang MY; Kvalheim G; Lingaas E; Giercksky KE
Shock; 1995 Jul; 4(1):68-73. PubMed ID: 7552781
[TBL] [Abstract][Full Text] [Related]
19. Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process.
Gross-Weege W; Weiss M; Schneider M; Wenning M; Harms B; Dumon K; Ohmann C; Röher HD
Intensive Care Med; 1997 Jan; 23(1):16-22. PubMed ID: 9037635
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
